Natera, Inc.
NASDAQ:NTRA · NASDAQ Global Select
+$2.23 today
Vol 2.63M · Avg 1.41M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+35.83%
Period High
$254.40
Period Low
$133.66
Latest
$231.41
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Teva Pharmaceutical Industries Limited
NYSE:TEVA
$36.61B
IQVIA Holdings Inc.
NYSE:IQV
$28.05B
DexCom, Inc.
NASDAQ:DXCM
$27.83B
Koninklijke Philips N.V.
NYSE:PHG
$26.02B
Illumina, Inc.
NASDAQ:ILMN
$24.53B
Waters Corporation
NYSE:WAT
$23.26B
Mettler-Toledo International Inc.
NYSE:MTD
$23.17B
BioNTech SE
NASDAQ:BNTX
$23.08B
Quest Diagnostics Incorporated
NYSE:DGX
$21.44B
STERIS plc
NYSE:STE
$19.70B
What is the latest NTRA filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does NTRA have?
Intrinsic Alpha currently shows 20 recent filings for NTRA.
Explore More
Continue the stock analysis
Jump to another research area for this company.